Bill Detail

H.R. 3493

Congress: 119

Title

Global Fairness in Drug Pricing Act

Summary

No summary published on Congress.gov yet — common for recently introduced bills.

Sponsor

Rep. Ro Khanna [D-CA-17]

Status

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Status as of Jul 27, 11:21 AM · synced 18d ago

Introduced

2025-05-19

Data source mode: congress-gov

Bill Engagement

Lobbyists on the case

1 org · 12 lobbyists · 1 filing mention H.R. 3493 (Global Fairness in Drug Pricing Act) in LDA disclosures.
Top orgs filing
Lobbyists on this bill
+ 10 more in the full intelligence view

Prepared intelligence brief

Put this record in the joined picture.

Unlock every organization and lobbyist filing on this bill, the complete event and issue map, private team positions, and recurring movement alerts across the portfolio.

Get your intelligence briefAlready a customer? Sign inGet free intelligence alerts →